The 14th Annual Pharmaceutical IT Congress promised an in-depth look into the future innovations of technology in the life sciences industry, and I have to say, London did not disappoint.
On September 28-29, I joined over 150 pharmaceutical information technology and business specialists as we dove into key topics that are currently top of mind for the industry. Our main focus was on IT's role in the digital transformation journey; including:
We also considered the current challenges impeding Pharma innovation; such as, disparate systems that make information difficult to synthesize, and the lack of strong data governance and process controls in outdated technology.
My joint presentation with Sanofi touched on many of these issues and areas of interest, sparking a lot of engaging conversations.
After speaking with leaders in the pharmaceutical industry, it is very clear to me that digital transformation isn't something that can be implemented in the distant future, it is a very real need today. Life science companies are buckling under the weight of ever-growing regulations and are getting lost in a maze of scattered data. Legacy systems are hurting, more than helping their business processes, ultimately endangering their relationships and reputations.
Luckily, the shift toward digital transformation in the pharmaceutical industry has already begun. You can see how Appian is helping one of the leading pharma companies achieve innovation in this use case.
If you would like to discuss these topics further, or have any questions, please feel free to contact me at email@example.com.
Life Sciences Global Practice Leader
Appian is a software company that automates business processes. The Appian AI Process Platform includes everything you need to design, automate, and optimize even the most complex processes, from start to finish. The world's most innovative organizations trust Appian to improve their workflows, unify data, and optimize operations—resulting in better growth and superior customer experiences.